A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among high-risk cancer patients undergoing chemotherapy treatment using anthracyclines ...

Altered sphingolipid biosynthetic flux and lipoprotein trafficking contribute to trans fat-induced atherosclerosis - (https:/ ...

Drug discovery researchers have found that a natural fat molecule called 'lipoxin A4' (LXA4) could significantly reduce inflammation and improve function for diabetic hearts.

A widely used heart failure medication called sacubitril/valsartan was associated with a lower risk of heart damage compared ...

Cardiovascular disease (CVD) is the leading cause of death globally, with WHO estimates stating it represents 32% of deaths ...

Monash University drug discovery researchers have found that a natural fat molecule called "lipoxin A4" (LXA4) could ...

Using a gene-screening method they created, Stanford Medicine researchers may have discovered why an effective chemotherapy ...

Australian researchers have discovered that a natural fat molecule could serve as a treatment for diabetes-induced heart disease In a new study publi ...

The preclinical study, published in Cardiovascular Diabetology, found LXA4, which is known for its "calming agent" action in ...

Weight-Loss Drug Reduces Risk of Early Death for Patients With Heart Failure, Trial Finds Nov ... recently that heart muscle cells grown from induced pluripotent stem cells can integrate into ...